Most of the patients with diabetes included in the study were prescribed with metformin alone or metformin with hypoglycemic drugs other than the SGLT2 inhibitors or GLP1-RA, even after the recommendation of guidelines. Here, SLC5A2 is linked to diabetes mellitus.